3D engineering for optic neuropathy treatment.
3D engineering for optic neuropathy treatment.
复制标题
DOI:
10.1016/j.drudis.2020.09.034
复制
发表时间:
2021-01
影响因子:
7.4
通讯作者:
Xu Q
中科院分区:
文献类型:
--
作者:
Xuan W;Moothedathu AA;Meng T;Gibson DC;Zheng J;Xu Q
Ocular disorders, such as age-related macular degeneration (AMD), diabetic retinopathy (DR), retinitis pigmentosa (RP), and glaucoma, can cause irreversible visual loss, and affect the quality of life of millions of patients. However, only very few 3D systems can mimic human ocular pathophysiology, especially the retinal degenerative diseases, which involve the loss of retinal ganglion cells (RGCs), photoreceptors, or retinal pigment epithelial cells (RPEs). In this review, we discuss current progress in the 3D modeling of ocular tissues, and review the use of the aforementioned technologies for optic neuropathy treatment according to the categories of associated disease models and their applications in drug screening, mechanism studies, and cell and gene therapies. 3D models can reduce animal testing, evaluate targeted drug delivery, and accelerate drug development process; they also have promising applications in cell and gene therapies, especially for retinal degenerative diseases and/or optic neuropathies that are difficult to mimic in vivo.
登录
查看更多内容
影响因子:
3.4
作者:
Aoki, Hitomi;Hara, Akira;Kunisada, Takahiro
通讯作者:
Kunisada, Takahiro
影响因子:
3.5
作者:
Carelli V;La Morgia C;Ross-Cisneros FN;Sadun AA
通讯作者:
Sadun AA
影响因子:
5.9
作者:
DiStefano T;Chen HY;Panebianco C;Kaya KD;Brooks MJ;Gieser L;Morgan NY;Pohida T;Swaroop A
通讯作者:
Swaroop A
影响因子:
5.9
作者:
Assawachananont, Juthaporn;Mandai, Michiko;Okamoto, Satoshi;Yamada, Chikako;Eiraku, Mototsugu;Yonemura, Shigenobu;Sasai, Yoshiki;Takahashi, Masayo
通讯作者:
Takahashi, Masayo
影响因子:
46.9
作者:
da Cruz, Lyndon;Fynes, Kate;Coffey, Peter J.
通讯作者:
Coffey, Peter J.